T1	PROC 44 98	Estudio de fase 3 de extensión a largo plazo y abierto
T2	Date 75 88	a largo plazo
T3	CHEM 102 112	apremilast
#1	AnnotatorNotes T3	C1678805; apremilast; Organic Chemical · Pharmacologic Substance
T4	LIVB 116 121	niños
#2	AnnotatorNotes T4	C0008059; Child; Age Group | C0870221; Boys; Age Group
T5	Age 116 121	niños
T6	DISO 126 141	úlceras bucales
#3	AnnotatorNotes T6	C0038363; Aphthous Stomatitis; Disease or Syndrome | C0149745; Oral Ulcer; Disease or Syndrome | C0542250; Ulcer buccal; Disease or Syndrome
T7	DISO 157 177	enfermedad de Behçet
#4	AnnotatorNotes T7	C0004943; Behcet Syndrome; Disease or Syndrome
T8	DISO 184 211	artritis psoriásica juvenil
#5	AnnotatorNotes T8	C0409672
T9	PROC 232 301	Estudio de fase 3 de extensión a largo plazo, multicéntrico y abierto
T10	Date 263 276	a largo plazo
T11	CHEM 305 315	apremilast
#6	AnnotatorNotes T11	C1678805; apremilast; Organic Chemical · Pharmacologic Substance
T12	LIVB 319 324	niños
#7	AnnotatorNotes T12	C0008059; Child; Age Group | C0870221; Boys; Age Group
T13	Age 319 324	niños
T14	Age 328 340	2 años o más
T15	DISO 345 360	úlceras bucales
#8	AnnotatorNotes T15	C0038363; Aphthous Stomatitis; Disease or Syndrome | C0149745; Oral Ulcer; Disease or Syndrome | C0542250; Ulcer buccal; Disease or Syndrome
T16	DISO 376 396	enfermedad de Behçet
#9	AnnotatorNotes T16	C0004943; Behcet Syndrome; Disease or Syndrome
T17	Age 402 414	5 años o más
T18	DISO 419 446	artritis psoriásica juvenil
#10	AnnotatorNotes T18	C0409672
T19	DISO 468 470	EB
#11	AnnotatorNotes T19	C0007117; Basal cell carcinoma; Neoplastic Process | C0014121; Bacterial Endocarditis; Disease or Syndrome
T20	DISO 472 507	inflamación en los vasos sanguineos
T21	DISO 524 549	ulceras bucales/genitales
T22	DISO 552 577	lesiones en los ojos/piel
T23	DISO 579 582	AIJ
#12	AnnotatorNotes T23	C1384600; Systemic onset juvenile chronic arthritis; Disease or Syndrome
T24	DISO 584 617	inflamación de las articulaciones
T25	DISO 622 641	desorden psoriasico
T26	LIVB 655 670	pts pediatricos
T27	Age 659 670	pediatricos
T28	LIVB 695 702	Sujetos
#13	AnnotatorNotes T28	C0681850; Study Subject; Group
T29	DISO 707 727	enfermedad de Behçet
#14	AnnotatorNotes T29	C0004943; Behcet Syndrome; Disease or Syndrome
T30	DISO 730 757	artritis psoriásica juvenil
#15	AnnotatorNotes T30	C0409672
T31	LIVB 797 816	representante legal
T32	LIVB 832 838	sujeto
#16	AnnotatorNotes T32	C0681850; Study Subject; Group
T33	PROC 850 874	consentimiento informado
#17	AnnotatorNotes T33	C0567423; Informed consent for procedure; Therapeutic or Preventive Procedure
T34	LIVB 885 891	sujeto
#18	AnnotatorNotes T34	C0681850; Study Subject; Group
T35	Age 906 921	demasiado joven
T36	PROC 934 958	consentimiento informado
#19	AnnotatorNotes T36	C0567423; Informed consent for procedure; Therapeutic or Preventive Procedure
T37	LIVB 964 970	sujeto
#20	AnnotatorNotes T37	C0681850; Study Subject; Group
T38	PROC 1098 1111	procedimiento
T39	LIVB 1142 1148	sujeto
#21	AnnotatorNotes T39	C0681850; Study Subject; Group
T40	PROC 1193 1204	tratamiento
#22	AnnotatorNotes T40	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T41	CHEM 1216 1226	apremilast
#23	AnnotatorNotes T41	C1678805; apremilast; Organic Chemical · Pharmacologic Substance
T42	CHEM 1334 1341	fármaco
#24	AnnotatorNotes T42	C0013227; Pharmaceutical Preparations; Pharmacologic Substance
T43	LIVB 1393 1399	sujeto
#25	AnnotatorNotes T43	C0681850; Study Subject; Group
T44	PROC 1425 1448	índice de masa corporal
T45	PROC 1450 1453	IMC
T46	LIVB 1617 1622	niños
#26	AnnotatorNotes T46	C0008059; Child; Age Group | C0870221; Boys; Age Group
T47	Age 1617 1622	niños
T48	LIVB 1625 1637	adolescentes
#27	AnnotatorNotes T48	C0205653; Adolescent (age group); Age Group
T49	Age 1625 1637	adolescentes
T50	Date 1644 1648	2000
T51	PROC 1670 1684	aleatorización
#28	AnnotatorNotes T51	C0034656; Randomization; Research Activity
T52	LIVB 1692 1698	sujeto
#29	AnnotatorNotes T52	C0681850; Study Subject; Group
T53	PROC 1741 1748	visitas
T54	PROC 1784 1793	protocolo
#30	AnnotatorNotes T54	C0008971; Clinical Protocols; Therapeutic or Preventive Procedure
T55	LIVB 1823 1829	sujeto
#31	AnnotatorNotes T55	C0681850; Study Subject; Group
T56	CHEM 1919 1929	apremilast
#32	AnnotatorNotes T56	C1678805; apremilast; Organic Chemical · Pharmacologic Substance
T57	PROC 2073 2079	visita
T58	LIVB 2139 2146	sujetos
#33	AnnotatorNotes T58	C0681850; Study Subject; Group
T59	PROC 2211 2218	Cirugía
#34	AnnotatorNotes T59	C0543467; Operative Surgical Procedures; Therapeutic or Preventive Procedure
T60	PROC 2238 2252	intervenciones
#35	AnnotatorNotes T60	C0184661; Interventional procedure; Therapeutic or Preventive Procedure
T61	LIVB 2274 2280	sujeto
#36	AnnotatorNotes T61	C0681850; Study Subject; Group
T62	LIVB 2327 2349	Mujeres en edad fértil
T63	Age 2338 2349	edad fértil
T64	LIVB 2382 2387	mujer
#37	AnnotatorNotes T64	C0043210; Woman; Population Group | C0242665; wife; Family Group
T65	Age 2404 2415	edad fértil
T66	Age 2425 2434	≥ 12 años
T67	PHYS 2450 2459	menarquia
#38	AnnotatorNotes T67	C0025274; Menarche; Organism Function
T68	Neg_cue 2488 2490	no
T69	PROC 2522 2543	método anticonceptivo
#39	AnnotatorNotes T69	C0700589; Contraceptive methods; Therapeutic or Preventive Procedure
T70	Negated 2522 2543	método anticonceptivo
T71	PROC 2563 2572	protocolo
#40	AnnotatorNotes T71	C0008971; Clinical Protocols; Therapeutic or Preventive Procedure
T72	PROC 2624 2635	tratamiento
#41	AnnotatorNotes T72	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T73	Duration 2646 2657	los 30 días
T74	PROC 2675 2689	administración
#42	AnnotatorNotes T74	C1533734; Administration procedure; Therapeutic or Preventive Procedure
T75	CHEM 2713 2738	producto en investigación
T76	LIVB 2743 2750	Mujeres
#43	AnnotatorNotes T76	C0043210; Woman; Population Group | C0242665; wife; Family Group
T77	Duration 2808 2819	los 30 días
T78	CHEM 2854 2879	producto en investigación
T79	LIVB 2884 2906	Mujeres en edad fértil
T80	Age 2895 2906	edad fértil
T81	PROC 2915 2933	prueba de embarazo
#44	AnnotatorNotes T81	C0032976; Pregnancy Tests; Diagnostic Procedure
T82	Date 2953 2964	la semana 0
T83	PROC 2978 3013	prueba de embarazo en suero u orina
T84	LIVB 3055 3061	sujeto
#45	AnnotatorNotes T84	C0681850; Study Subject; Group
T85	DISO 3075 3087	sensibilidad
T86	PROC 3155 3166	tratamiento
#46	AnnotatorNotes T86	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T87	LIVB 3190 3196	sujeto
#47	AnnotatorNotes T87	C0681850; Study Subject; Group
T88	Neg_cue 3197 3199	no
T89	PROC 3241 3248	visitas
T90	PROC 3279 3288	protocolo
#48	AnnotatorNotes T90	C0008971; Clinical Protocols; Therapeutic or Preventive Procedure
T91	PROC 1088 1097	actividad
T92	PROC 1522 1589	tabla de crecimiento de los Centros para el Control de Enfermedades
T93	PROC 2007 2022	escala Columbia
T94	Spec_cue 2039 2045	riesgo
T95	Speculated 2049 2057	suicidio
T96	DISO 2049 2057	suicidio
T97	PROC 2059 2065	C-SSRS
T98	PROC 2028 2057	evaluar el riesgo de suicidio
T99	Date 1171 1183	la semana 52
T100	Date 2083 2095	la semana 52
T101	PROC 3130 3143	administrarán
T102	Negated 3241 3248	visitas
T103	PROC 1890 1914	continuar el tratamiento
T104	Quantifier_or_Qualifier 758 764	activa
T105	Observation 982 994	asentimiento
T106	Quantifier_or_Qualifier 1205 1211	activo
T107	Quantifier_or_Qualifier 1350 1360	disponible
T108	Result_or_Value 1492 1515	inferior al percentil 5
T109	CONC 1522 1530	tabla de
T110	Observation 1704 1713	dispuesto
T111	Observation 1799 1804	capaz
T112	CONC 1849 1874	relación beneficio-riesgo
T113	CONC 2007 2057	escala Columbia para evaluar el riesgo de suicidio
T114	CONC 2059 2065	C-SSRS
T115	Quantifier_or_Qualifier 2219 2229	programada
T116	Observation 2295 2322	participación en el estudio
T117	Observation 2497 2507	dispuestas
T118	CONC 2696 2708	última dosis
T119	Observation 2755 2783	planean quedarse embarazadas
T120	CONC 2837 2849	última dosis
T121	Result_or_Value 2934 2942	positiva
T122	Observation 3205 3260	disponible para completar todas las visitas del estudio
T123	Patient 116 121	niños
T124	Patient 319 324	niños
T125	Patient 655 670	pts pediatricos
T126	Patient 695 702	Sujetos
T127	Other 797 816	representante legal
T128	Patient 832 838	sujeto
T129	Patient 885 891	sujeto
T130	Patient 964 970	sujeto
T131	Patient 1142 1148	sujeto
T132	History_of 1216 1226	apremilast
T133	History_of 1232 1239	estudio
T134	Patient 1393 1399	sujeto
T135	Patient 1617 1622	niños
T136	Patient 1625 1637	adolescentes
T137	Patient 1692 1698	sujeto
T138	Patient 1823 1829	sujeto
T139	Patient 2139 2146	sujetos
T140	Future 2211 2218	Cirugía
T141	Future 2238 2252	intervenciones
T142	Patient 2274 2280	sujeto
T143	Patient 2327 2349	Mujeres en edad fértil
T144	Patient 2382 2387	mujer
T145	Patient 2743 2750	Mujeres
T146	Future 2772 2783	embarazadas
T147	Patient 2884 2906	Mujeres en edad fértil
T148	Patient 3055 3061	sujeto
T149	History_of 3075 3087	sensibilidad
T150	Patient 3190 3196	sujeto
